Yasin Keshvargar
Lawyers
Filters
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
Enbridge $9.38 billion Dominion Energy assets acquisition financing
We are advising the arrangers and agent on the transaction
Tetra Tech $575 million convertible notes offering and capped call transactions
The 2.25% convertible senior notes are due 2028
Gracell Biotechnologies PIPE of ordinary shares and warrants
The company’s ADSs are listed on Nasdaq
BMS $35 million investment in Immatics
We advised Immatics on the private placement of ordinary shares
Korro Bio $117 million private placement
The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics
Samarco Mineração enters into restructuring support agreement
We are advising an ad hoc group in connection with the restructuring
XPO $1.28 billion senior notes offerings
The senior notes are due 2028 and 2031
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction